Search for: "CEPHALON, INC"
Results 101 - 120
of 169
Sorted by Relevance
|
Sort by Date
16 Oct 2008, 3:27 pm
Cephalon Inc., No. 07-2702 (3rd Cir. [read post]
11 Nov 2008, 10:50 pm
The largest recoveries were from pharmaceutical companies--Cephalon Inc., Merck & Co. and CVS Caremark Corp. paid more than $640 million. [read post]
19 Mar 2016, 10:13 am
Cephalon, Inc. v. [read post]
29 Jun 2011, 3:34 am
Apotex Inc. et al. [read post]
18 Aug 2010, 12:19 am
Eon Labs, Inc. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) (Patent Quality Review Blog) Nuvigil (Armodafinil) – US: Patent infringement complaint filed following a Para IV certification: Cephalon, Inc. et al. v. [read post]
13 Jan 2014, 4:02 am
Take for example, the pharmaceuticals case of Cephalon Inc v Orchid Europe Ltd [2010] EWHC 2945 (Pat) [briefly noted on PatLit here] in which Floyd J (as he was) treated the issue of who is likely to suffer the most irreparable harm as the key factor in the balance of convenience assessment itself: "Balance of convenienceThere is no dispute as to the approach which I should apply. [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
30 Nov 2017, 8:59 pm
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
19 May 2010, 6:15 am
Immutopics, Inc. [read post]
29 Jul 2013, 12:16 pm
Cephalon Inc. et al. v. [read post]
20 Mar 2014, 7:48 am
Cephalon, Inc. v. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
10 Jul 2013, 12:00 am
While synthesizing and screening compounds is considered routine experimentation, the Court noted in Cephalon, Inc. v. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
10 Oct 2007, 9:15 pm
Manufactured by Cephalon, Inc., Fentora is most commonly prescribed to treat breakthrough pain in terminal cancer patients who have already developed a tolerance to opioid pain medications. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against APP Pharmaceuticals following Para IV challenge (Patent Docs)… [read post]
25 Apr 2012, 1:56 pm
The FTC has another “pay-for-delay” action pending against pharmaceutical manufacturer Cephalon, Inc. for allegedly restraining competition for its branded drug, Provigil, by paying four competing firms to refrain from selling generic versions of the drug. [read post]
